Last 48 quarters of trend data · Healthcare · Eye & Dental Care
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 23.97 | 19.13 | 27.74 | 27.30 | 20.65 | 40.13 | 27.52 | 31.27 | 37.50 | 41.02 | 47.15 | 58.98 | 41.77 | 48.31 | 60.55 | 73.28 | 97.64 | 55.67 | 41.09 | 64.12 | 68.46 |
| — | -52.3% | +0.8% | -12.7% | -44.9% | -2.2% | -41.6% | -47.0% | -10.2% | -15.1% | -22.1% | -19.5% | -57.2% | -13.2% | +47.4% | +14.3% | +42.6% | -23.7% | -32.5% | +18.9% | +2.5% | |
| P/S Ratio | 2.86 | 2.54 | 2.86 | 2.95 | 2.67 | 2.28 | 3.39 | 2.99 | 3.90 | 4.86 | 4.41 | 6.19 | 5.43 | 6.11 | 6.77 | 6.83 | 4.54 | 4.55 | 4.79 | 8.87 | 12.66 |
| — | +11.7% | -15.7% | -1.2% | -31.4% | -53.2% | -23.1% | -51.8% | -28.1% | -20.4% | -34.7% | -9.4% | +19.5% | +34.2% | +41.1% | -23.0% | -64.1% | -65.1% | -60.2% | -26.5% | -0.6% | |
| P/B Ratio | 2.98 | 2.40 | 2.85 | 2.96 | 2.77 | 2.29 | 3.51 | 3.08 | 4.03 | 4.82 | 4.83 | 6.57 | 5.72 | 6.17 | 7.45 | 7.40 | 4.55 | 4.39 | 5.16 | 9.42 | 14.41 |
| — | +4.6% | -18.7% | -4.0% | -31.3% | -52.5% | -27.3% | -53.1% | -29.5% | -21.9% | -35.2% | -11.3% | +25.8% | +40.7% | +44.3% | -21.4% | -68.4% | -70.9% | -64.1% | -26.1% | +9.7% | |
| P/FCF | 16.86 | 36.12 | 13.51 | 25.52 | 9.67 | 18.55 | 22.32 | 106.75 | 14.75 | 20.32 | 42.68 | 320.03 | 385.08 | 22.08 | 35.09 | 47.44 | 44.76 | 21.19 | 91.08 | — | 79.69 |
| — | +94.7% | -39.5% | -76.1% | -34.5% | -8.7% | -47.7% | -66.6% | -96.2% | -8.0% | +21.6% | +574.6% | +760.3% | +4.2% | -61.5% | — | -43.8% | -63.0% | +44.7% | — | +146.3% | |
| EV / EBITDA | 15.01 | 13.71 | 41.57 | 12.36 | 9.79 | 13.46 | 15.92 | 16.06 | 20.03 | 22.61 | 23.92 | 32.02 | 24.31 | 27.47 | 31.65 | 37.00 | 26.59 | 21.72 | 20.41 | 37.03 | 51.13 |
| — | +1.8% | +161.1% | -23.1% | -51.1% | -40.5% | -33.4% | -49.8% | -17.6% | -17.7% | -24.4% | -13.5% | -8.6% | +26.4% | +55.1% | -0.1% | -48.0% | -51.5% | -49.5% | -11.8% | +17.0% | |
| EV / EBIT | 17.73 | 13.71 | 18.87 | 19.03 | 14.50 | 13.11 | 18.68 | 20.22 | 20.61 | 27.87 | 24.60 | 37.82 | 26.99 | 33.58 | 38.24 | 46.92 | 31.36 | 26.59 | 23.69 | 42.57 | 57.98 |
| — | +4.5% | +1.0% | -5.9% | -29.7% | -52.9% | -24.0% | -46.5% | -23.6% | -17.0% | -35.7% | -19.4% | -13.9% | +26.3% | +61.4% | +10.2% | -45.9% | -46.3% | -46.5% | -9.0% | +18.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.3% | 68.7% | 65.1% | 70.8% | 65.7% | 64.2% | 69.9% | 69.5% | 70.0% | 69.7% | 70.3% | 70.0% | 70.0% | 69.1% | 71.2% | 70.0% | 68.5% | 69.5% | 70.9% | 72.9% | 72.2% |
| — | +7.1% | -6.9% | +2.0% | -6.2% | -7.9% | -0.5% | -0.7% | +0.1% | +1.0% | -1.3% | -0.1% | +2.1% | -0.7% | +0.4% | -3.9% | -5.1% | -6.4% | -5.5% | -3.7% | -1.3% | |
| Operating Margin | 15.3% | 16.7% | 11.7% | 16.6% | 15.2% | 9.7% | 16.1% | 13.4% | 14.5% | 16.6% | 14.3% | 15.5% | 17.9% | 17.3% | 17.2% | 14.2% | 12.5% | 16.1% | 19.4% | 20.4% | 21.4% |
| — | +72.4% | -27.5% | +24.0% | +5.2% | -41.7% | +12.6% | -13.4% | -19.2% | -4.2% | -16.7% | +9.2% | +43.5% | +7.4% | -11.6% | -30.4% | -41.7% | -37.2% | -27.0% | -19.2% | -16.1% | |
| Net Margin | 10.2% | 13.3% | 10.3% | 10.8% | 13.0% | 5.7% | 12.3% | 9.5% | 10.4% | 11.9% | 9.4% | 10.5% | 13.0% | 12.6% | 11.2% | 9.3% | 4.6% | 8.2% | 11.6% | 13.8% | 18.5% |
| — | +133.5% | -16.7% | +13.9% | +24.2% | -51.9% | +31.1% | -9.6% | -19.5% | -6.2% | -15.8% | +13.1% | +179.7% | +54.9% | -4.1% | -32.5% | -75.0% | -54.2% | -41.1% | -38.4% | -2.8% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.4% | 3.2% | 2.6% | 2.8% | 3.4% | 1.4% | 3.2% | 2.4% | 2.7% | 3.0% | 2.6% | 2.8% | 3.3% | 3.3% | 3.1% | 2.5% | 1.1% | 2.0% | 3.1% | 3.7% | 5.3% |
| — | +119.3% | -20.1% | +12.8% | +27.3% | -52.1% | +25.9% | -14.2% | -20.2% | -7.8% | -18.2% | +14.6% | +191.4% | +63.7% | +1.2% | -32.7% | -78.6% | -62.0% | -47.3% | -39.1% | +5.4% | |
| ROA | 6.6% | 2.1% | 1.7% | 1.8% | 2.2% | 0.9% | 2.0% | 1.5% | 1.7% | 1.9% | 1.6% | 1.7% | 2.0% | 1.9% | 1.9% | 1.5% | 0.7% | 1.2% | 1.9% | 2.3% | 3.3% |
| — | +129.0% | -15.9% | +18.7% | +32.0% | -50.8% | +29.0% | -11.8% | -17.5% | -5.0% | -15.5% | +15.8% | +183.9% | +57.1% | -3.3% | -34.4% | -78.6% | -62.1% | -49.7% | -44.2% | -4.2% | |
| ROIC | 15.4% | 3.9% | 2.9% | 4.1% | 3.9% | 2.3% | 4.0% | 3.3% | 3.6% | 4.0% | 3.6% | 4.0% | 4.7% | 4.5% | 4.6% | 3.6% | 3.0% | 3.8% | 4.9% | 5.4% | 6.6% |
| — | +66.3% | -27.7% | +24.9% | +7.1% | -41.2% | +10.4% | -16.8% | -22.3% | -12.7% | -22.2% | +9.9% | +53.6% | +18.0% | -6.7% | -33.1% | -53.9% | -53.3% | -41.9% | -25.1% | +0.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 |
| — | +11.0% | -9.2% | -10.5% | -8.7% | -5.3% | -8.5% | -7.1% | -11.2% | -3.0% | -6.3% | -7.7% | -1.0% | +2.0% | +7.4% | +2.6% | +1.8% | +19.2% | +19.5% | +41.2% | +29.9% | |
| Debt / EBITDA | 0.13 | 0.86 | 1.81 | 0.51 | 0.44 | 0.80 | 0.60 | 0.70 | 0.65 | 0.64 | 0.70 | 0.68 | 0.62 | 0.62 | 0.64 | 0.75 | 0.87 | 0.69 | 0.56 | 0.57 | 0.50 |
| — | +7.9% | +199.6% | -27.3% | -33.1% | +25.1% | -14.2% | +3.0% | +6.1% | +2.3% | +9.7% | -9.7% | -28.9% | -9.3% | +14.1% | +30.9% | +73.2% | +105.6% | +71.5% | +68.2% | +38.2% | |
| Current Ratio | 1.36 | 1.42 | 1.40 | 1.39 | 1.36 | 1.29 | 1.23 | 1.21 | 1.22 | 1.26 | 1.18 | 1.23 | 1.18 | 1.27 | 1.17 | 1.16 | 1.26 | 1.38 | 1.32 | 1.33 | 1.30 |
| — | +10.6% | +13.7% | +15.5% | +11.4% | +2.4% | +3.7% | -1.6% | +3.3% | -1.1% | +1.1% | +5.4% | -6.0% | -7.9% | -11.2% | -12.6% | -2.9% | +0.8% | +0.1% | -12.3% | -7.1% | |
| Quick Ratio | 1.24 | 1.31 | 1.28 | 1.28 | 1.24 | 1.17 | 1.10 | 1.08 | 1.10 | 1.14 | 1.06 | 1.09 | 1.04 | 1.13 | 1.02 | 1.01 | 1.08 | 1.20 | 1.15 | 1.18 | 1.18 |
| — | +11.5% | +16.2% | +18.3% | +13.4% | +3.3% | +4.7% | -0.4% | +5.6% | +0.2% | +3.3% | +7.9% | -3.9% | -5.9% | -10.8% | -14.8% | -8.0% | -4.1% | -5.3% | -16.1% | -8.8% | |
| Interest Coverage | — | — | — | — | — | 99.78 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALGN stock.
Align Technology, Inc.'s current P/E is 24.0x. The average P/E over the last 4 quarters is 23.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Align Technology, Inc.'s current operating margin is 15.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Align Technology, Inc.'s business trajectory between earnings reports.